World's Best Scientists 2026 revealed!
Mark R. Litzow

Mark R. Litzow

D-Index & Metrics

Medicine

D-Index
123
Citations
55915
World Ranking
3356
National Ranking
1845

Overview

Mark R. Litzow is affiliated with the Mayo Clinic in the United States and has a significant research footprint in the field of medicine, particularly within hematology. Their research encompasses various subfields, including genetics, public health, environmental and occupational health, molecular biology, and oncology.

The main topics of Mark R. Litzow's work include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Chronic Lymphocytic Leukemia Research
  • CAR-T Cell Therapy Research

Mark R. Litzow has contributed to publications in several key venues. The most frequent publication venues include:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • American Journal of Hematology
  • Blood Cancer Journal

Some notable recent papers featuring Mark R. Litzow include:

  • Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial, 2022, Blood
  • Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial, 2020, Nature Medicine
  • American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults, 2020, Blood Advances
  • Palliative Care for Patients With Cancer: ASCO Guideline Update, 2024, Journal of Clinical Oncology

Frequent co-authors who have collaborated extensively with Mark R. Litzow include:

  • Hassan B. Alkhateeb
  • William J. Hogan
  • Mrinal M. Patnaik
  • Mithun Vinod Shah
  • Aref Al-Kali

Best Publications

  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

    Jay P. Patel;Mithat Gönen;Maria E. Figueroa;Hugo Fernandez

  • Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

    Max S. Topp;Nicola Gökbuget;Anthony S. Stein;Gerhard Zugmaier

  • MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    Animesh D. Pardanani;Ross L. Levine;Terra Lasho;Yana Pikman

  • Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Hugo F. Fernandez;Zhuoxin Sun;Xiaopan Yao;Mark R. Litzow

  • Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

    Hagop M. Kantarjian;Francis Giles;Norbert Gattermann;Kapil Bhalla

  • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Anthony H. Goldstone;Susan M. Richards;Hilliard M. Lazarus;Martin S. Tallman

  • Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

    Jennifer A Woyach;Amy S Ruppert;Nyla A Heerema;Weiqiang Zhao

  • Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

    Adele K. Fielding;Susan M. Richards;Rajesh Chopra;Hillard M. Lazarus

  • Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

    Jacob M. Rowe;Georgina Buck;Alan Kenneth Burnett;Raj Chopra

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    Tait D. Shanafelt;Xin V. Wang;Neil E. Kay;Curtis A. Hanson

  • International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

    Andrew C. Harris;Andrew C. Harris;Rachel Young;Rachel Young;Steven Devine;William J. Hogan

  • First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

    Paul J. Martin;J. Douglas Rizzo;John R. Wingard;Karen Ballen

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Anthony V. Moorman;Christine J. Harrison;Georgina A.N. Buck;Sue M. Richards

  • Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure

    Michel Duval;John P. Klein;Wensheng He;Jean Yves Cahn

  • Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    Alexander E. Perl;Jessica K. Altman;Jorge Cortes;Catherine Smith

  • Hematologic manifestations of celiac disease.

    Thorvardur R. Halfdanarson;Mark R. Litzow;Joseph A. Murray

  • Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

    Morie A. Gertz;Martha Q. Lacy;Angela Dispenzieri;Philip R. Greipp

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia

    A Moorman;C J Harrison;Buck Gan.;S M Richards

Frequent Co-Authors

Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Morie A. Gertz
Morie A. Gertz Mayo Clinic
Martha Q. Lacy
Martha Q. Lacy Mayo Clinic
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Martin S. Tallman
Martin S. Tallman Northwestern University
David J. Inwards
David J. Inwards Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are many online programs designed to support individuals pursuing medical and healthcare careers in the USA. As demand grows for skilled healthcare professionals, online degrees offer flexibility and affordability for students balancing work, family, or other commitments. Specializing in health administration, pharmacy, nursing, or information management can open up new pathways within the healthcare sector.

For those interested in administrative roles, the cheapest online mha programs can help you gain leadership and management skills essential for running healthcare facilities. If advanced nursing is your interest, you might consider the cheapest dnp programs to pursue your Doctor of Nursing Practice online at a lower cost.

Aspiring pharmacists can explore the cheapest online pharmacy school options, which prepare graduates for vital roles in medication management and patient care. Additionally, technology-focused students can opt for online rhit degree programs to enter the high-demand field of health information management.

Choosing the right online degree not only keeps costs down but also broadens your career opportunities, allowing you to make a meaningful impact in healthcare.

Best Scientists Citing Mark R. Litzow

Trending Scientists

Recently Published Articles